DCM
EXAS

Driehaus Capital Management’s Exact Sciences EXAS Stock Holding History

Driehaus Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-103,354
Closed -$7.65M – 406
2023
Q4 		$7.65M Sell
103,354
-105
-0.1% -$6.88K 0.09% 243
2023
Q3 		$7.06M Sell
103,459
-48,690
-32% -$4.13M 0.09% 251
2023
Q2 		$14.3M Buy
152,149
+36,035
+31% +$2.81M 0.18% 176
2023
Q1 		$7.87M Buy
+116,114
New +$7.46M 0.11% 249
2022
Q4 		– Sell
-39,038
Closed -$1.27M – 369
2022
Q3 		$1.27M Hold
39,038
– – 0.02% 303
2022
Q2 		$1.54M Buy
39,038
+9,773
+33% +$523K 0.02% 297
2022
Q1 		$2.05M Sell
29,265
-56,984
-66% -$4.17M 0.03% 319
2021
Q4 		$6.71M Buy
86,249
+155
+0.2% +$13.7K 0.07% 274
2021
Q3 		$8.22M Buy
86,094
+41,523
+93% +$4.38M 0.1% 259
2021
Q2 		$5.54M Sell
44,571
-3,429
-7% -$409K 0.07% 273
2021
Q1 		$6.33M Buy
48,000
+38,759
+419% +$5.31M 0.09% 261
2020
Q4 		$1.22M Buy
+9,241
New +$1.12M 0.02% 310
2020
Q1 		– Sell
-6,947
Closed -$642K – 442
2019
Q4 		$642K Sell
6,947
-5,948
-46% -$523K 0.02% 343
2019
Q3 		$1.17M Buy
12,895
+2,286
+22% +$260K 0.04% 293
2019
Q2 		$1.25M Buy
10,609
+3,331
+46% +$336K 0.04% 253
2019
Q1 		$630K Buy
7,278
+3,774
+108% +$321K 0.02% 305
2018
Q4 		$221K Buy
+3,504
New +$240K 0.01% 388
2018
Q3 		– Sell
-59,651
Closed -$3.57M – 485
2018
Q2 		$3.57M Buy
+59,651
New +$3.21M 0.12% 208
2018
Q1 		– Sell
-58,008
Closed -$3.05M – 519
2017
Q4 		$3.05M Sell
58,008
-60,740
-51% -$3.24M 0.12% 215
2017
Q3 		$5.59M Buy
118,748
+20,541
+21% +$827K 0.22% 123
2017
Q2 		$3.47M Sell
98,207
-14,790
-13% -$457K 0.13% 186
2017
Q1 		$2.67M Buy
+112,997
New +$2.24M 0.09% 224
2016
Q4 		– Sell
-11,670
Closed -$217K – 573
2016
Q3 		$217K Buy
+11,670
New +$206K 0.01% 472

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Driehaus Capital Management's EXAS Position: Q1 2024 in Review

Driehaus Capital Management sold out of Exact Sciences (EXAS) in Q1 2024, closing a stake of 103,354 shares — an estimated $7.65M sold.

Driehaus Capital Management first reported a position in EXAS in Q3 2016 and held it in 23 quarters. The position peaked at $14.3M in Q2 2023. 625 funds tracked by Wall St. Rank hold EXAS as of Q1 2024.

  • Driehaus Capital Management reported no remaining Exact Sciences position as of Q1 2024 after selling out during the quarter.
  • Driehaus Capital Management sold 103,354 Exact Sciences shares in Q1 2024, an estimated $7.65M.
  • Driehaus Capital Management first reported a position in Exact Sciences in Q3 2016 and held it in 23 quarters.
  • Driehaus Capital Management's Exact Sciences position peaked at $14.3M in Q2 2023.
  • 625 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2024.

Based on Driehaus Capital Management's 13F filing for Q1 2024, filed 15 May 2024.